MC
TDACW

Meteora Capital’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Meteora Capital’s Portfolio TDACW Stock Details TDACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.8K Sell
189,507
-25,994
-12% -$5.95K ﹤0.01% 284
2025
Q4 		$60.3K Buy
215,501
+190,884
+775% +$62.6K 0.01% 246
2025
Q3 		$7.14K Buy
+24,617
New +$6.67K ﹤0.01% 263

Other funds holding TDACW

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Meteora Capital's TDACW Position: Q1 2026 in Review

Meteora Capital reduced its Translational Development Acquisition Corp Warrants (TDACW) stake by 12% in Q1 2026, selling an estimated $5.95K and leaving 189,507 shares worth $22.8K. The position accounts for ﹤0.01% of the portfolio, ranked #284.

Meteora Capital first reported a position in TDACW in Q3 2025 and has held it in 3 quarters since. The position peaked at $60.3K in Q4 2025. 32 funds tracked by Wall St. Rank hold TDACW as of Q1 2026.

  • Meteora Capital held 189,507 shares of Translational Development Acquisition Corp Warrants worth $22.8K as of Q1 2026.
  • Meteora Capital sold 25,994 Translational Development Acquisition Corp Warrants shares in Q1 2026, an estimated $5.95K.
  • Translational Development Acquisition Corp Warrants made up ﹤0.01% of Meteora Capital's portfolio in Q1 2026, its #284 holding.
  • Meteora Capital first reported a position in Translational Development Acquisition Corp Warrants in Q3 2025 and has held it in 3 quarters since.
  • Meteora Capital's Translational Development Acquisition Corp Warrants position peaked at $60.3K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q1 2026.

Based on Meteora Capital's 13F filing for Q1 2026, filed 15 May 2026.